A Study of ASKG315 in Patients With Advanced Solid Tumors.

Clinical trial NCT05554666 · UNKNOWN

Trial details

NCT number: NCT05554666
Sponsor: AskGene Pharma, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2022-10-15
Primary completion: 2023-12-31
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.